Northrop Grumman Shares Up 28% YTD With Its Biggest Upside Not Yet in Guidance

Core Viewpoint - Northrop Grumman's shares have increased by 28% year-to-date, driven by a new Air Force contract for B-21 bomber production, which is expected to significantly impact revenue in 2027 and 2028, although not included in the 2026 guidance [1] Financial Performance - Q4 2025 revenue reached $11.7 billion, reflecting a 9.6% year-over-year increase, with a record backlog of $95.7 billion and free cash flow of $3.235 billion, up 84% [1] - The Aeronautics Systems business grew by 18% in Q4 2025 [1] Market Sentiment - Northrop Grumman has a bullish social sentiment score of 63.53 as of March 11, 2026, primarily due to the new B-21 production contract and the record backlog [1] Growth Drivers - The defense spending environment is described as the strongest in years, with 2026 guidance projecting sales of $43.5-$44 billion and free cash flow of $3.1-$3.5 billion, excluding the B-21 ramp [1] - The B-21 acceleration deal is funded via reconciliation, representing potential upside not yet quantified for 2026 [1] Risks - The Sentinel ICBM program poses a risk due to delays in initial operating capability, now expected in 2033, and cost breaches that have led to a restructuring of the program's milestone schedule [1] - The stock is currently trading at 26-27 times earnings, above the analyst consensus target of $675, indicating that the market is pricing in execution [1]